Share-Based Payments (Tables)
|
12 Months Ended |
Dec. 31, 2022 |
Disclosure Of Sharebased Payment Arrangements Abstract |
|
Schedule of recognized a share based charge |
|
|
Year ended December 31 2022 |
|
|
Year ended December 31 2021 |
|
|
Year ended December 31 2020 |
|
|
|
£’000 |
|
|
£’000 |
|
|
£’000 |
|
|
|
|
|
|
|
|
|
|
|
Incentive Equity Plan |
|
|
44,312 |
|
|
|
13,599 |
|
|
|
- |
|
SAYE |
|
|
184 |
|
|
|
- |
|
|
|
- |
|
EMI prior to the Transaction |
|
|
- |
|
|
|
73 |
|
|
|
182 |
|
Unapproved prior to the Transaction |
|
|
- |
|
|
|
29,096 |
|
|
|
3,577 |
|
Modification at the Transaction |
|
|
- |
|
|
|
1,103 |
|
|
|
- |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
44,496 |
|
|
|
43,871 |
|
|
|
3,759 |
|
|
Schedule of options were granted |
Scheme |
|
Number |
|
|
Grant date |
|
Expiry date |
|
|
|
|
|
|
|
|
Incentive Equity Plan |
|
|
2,295,099 |
|
|
01/01/2022 |
|
01/01/2032 |
Incentive Equity Plan |
|
|
1,269,100 |
|
|
01/04/2022 |
|
01/04/2032 |
Incentive Equity Plan |
|
|
1,087,250 |
|
|
01/07/2022 |
|
01/07/2032 |
Incentive Equity Plan |
|
|
427,300 |
|
|
01/10/2022 |
|
01/10/2032 |
Incentive Equity Plan – Directors |
|
|
3,933,339 |
|
|
01/10/2022 |
|
01/10/2032 |
SAYE |
|
|
1,496,903 |
|
|
26/01/2022 |
|
31/08/2025 |
|
|
|
|
|
|
|
|
|
Total 2022 |
|
|
10,508,991 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Unapproved prior to the Transaction |
|
|
469,000 |
|
|
01/01/2021 |
|
01/01/2031 |
Unapproved prior to the Transaction |
|
|
2,023,516 |
|
|
01/04/2021 |
|
01/04/2031 |
Incentive Equity Plan |
|
|
23,915,248 |
|
|
01/10/2021 |
|
01/10/2031 |
|
|
|
|
|
|
|
|
|
Total 2021 |
|
|
26,407,764 |
|
|
|
|
|
|
Schedule of reconciles the share options outstanding |
|
|
EMI |
|
|
Unapproved |
|
|
Incentive Equity Plan |
|
|
SAYE |
|
|
|
Number of options |
|
|
Number of options |
|
|
Number of options |
|
|
Number of options |
|
At December 31, 2020 |
|
|
4,683,683 |
|
|
|
8,121,393 |
|
|
|
- |
|
|
|
- |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Granted prior to the Transaction |
|
|
- |
|
|
|
2,492,516 |
|
|
|
- |
|
|
|
- |
|
Forfeited prior to the Transaction |
|
|
(66,413 |
) |
|
|
(579,713 |
) |
|
|
- |
|
|
|
- |
|
Cash settled at the Transaction |
|
|
(34,690 |
) |
|
|
(44,114 |
) |
|
|
- |
|
|
|
- |
|
Replacements at the Transaction1 |
|
|
(4,582,580 |
) |
|
|
(9,990,082 |
) |
|
|
50,347,491 |
|
|
|
- |
|
Granted after the Transaction |
|
|
- |
|
|
|
- |
|
|
|
23,915,248 |
|
|
|
- |
|
At December 31, 2021 |
|
|
- |
|
|
|
- |
|
|
|
74,262,739 |
|
|
|
- |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Granted during the year |
|
|
- |
|
|
|
- |
|
|
|
9,012,088 |
|
|
|
1,496,903 |
|
Exercised during the year |
|
|
- |
|
|
|
- |
|
|
|
(9,513,868 |
) |
|
|
- |
|
Forfeited during the year |
|
|
- |
|
|
|
- |
|
|
|
(10,732,364 |
) |
|
|
(884,823 |
) |
Expired during the year |
|
|
- |
|
|
|
- |
|
|
|
(599,238 |
) |
|
|
- |
|
At December 31, 2022 |
|
|
- |
|
|
|
- |
|
|
|
62,429,357 |
|
|
|
612,080 |
|
|
1 |
The replacement options granted
at the Transaction reflect the exchange ratio established in the Business Combination Agreement. Refer to Note 1 for further details. |
|
Schedule of the determination of fair value of options granted |
|
|
Incentive Equity Plan |
|
Incentive Equity Plan – Executive Directors |
|
SAYE |
|
|
|
|
|
|
|
Valuation method |
|
N/A1 |
|
Monte-Carlo |
|
Black-Scholes |
Exercise price |
|
£nil
|
|
£nil |
|
£3.60 |
Expected volatility |
|
N/A |
|
98% |
|
53% |
Dividend yield |
|
Nil |
|
Nil |
|
Nil |
Risk free interest rate |
|
N/A |
|
4.2% |
|
1.2% |
Fair value per share |
|
£0.40 - £4.46 |
|
£0.31 |
|
£0.98 |
|
1 |
Considering that the Incentive
Equity Plan awards vest over time without any further restrictions, the fair value is equal to the Company’s closing stock price
as of the grant date. |
|
|
Unapproved |
|
Incentive Equity Plan |
|
Incentive Equity Plan – Executive Directors |
|
|
|
|
|
|
|
Valuation method |
|
Monte-Carlo |
|
N/A |
|
Monte-Carlo |
Exercise price |
|
£nil
|
|
£nil |
|
£nil |
Expected volatility |
|
50% |
|
N/A |
|
53% |
Dividend yield |
|
Nil |
|
Nil |
|
Nil |
Risk free interest rate |
|
0.0% |
|
N/A |
|
1.2% |
Fair value per share |
|
£8.27 - £23.74 |
|
£5.33 |
|
£2.93 |
|